Statistics

Total Visits

Views
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period107

File Visits

Downloads
35543-24.pdf64

Select a period of time:

Number of views in the range

Views
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period24

Number of downloads in the range

Downloads
35543-24.pdf11

Views

Views
May 20252
June 20252
July 202513
August 20251
September 20254
October 20252
November 20250
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • May 2025
    1
  • June 2025
    6
  • July 2025
    0
  • August 2025
    4
  • September 2025
    0
  • October 2025
    0
  • November 2025
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil9
United States8
United Kingdom2
Ecuador1
Mexico1
Singapore1
Trinidad and Tobago1
South Africa1
 

Top countries by downloads

Downloads
United States2
 

Top cities views

Views
Arapongas1
Bradenton1
Cabo Frio1
Chaguanas1
Columbus1
Cuenca1
Guapimirim1
Jequié1
Joanópolis1
Johannesburg1
 

Top cities by downloads

Downloads